Back to top
more

Stryker (SYK)

(Real Time Quote from BATS)

$380.57 USD

380.57
486,242

-0.92 (-0.24%)

Updated Aug 5, 2025 02:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (155 out of 246)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Stryker Launches MAKO Robotic-Arm for Knee Anthroplasty

by Zacks Equity Research

Stryker Corporation (SYK) recently announced the commercial launch of a robotic-arm assisted total knee arthroplasty application based on its flagship MAKO System.

    Zacks Equity Research

    Why Is Stryker Corp (SYK) Up 5% Since the Last Earnings Report?

    by Zacks Equity Research

    Stryker Corp (SYK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

      Zacks Equity Research

      Stryker (SYK) Beats Q4 Earnings, Provides FY17 Guidance

      by Zacks Equity Research

      Maintaining its streak of positive earnings surprises, Stryker Corp (SYK) reported adjusted earnings of $1.78 per share in the fourth quarter of 2016, which comfortably beat the Zacks Consensus Estimate by 2 cents.

        Zacks Equity Research

        Should You Sell Stryker (SYK) Before Earnings?

        by Zacks Equity Research

        Investors are always looking for stocks that are poised to beat at earnings season and Stryker Corporation (SYK) may be one such company.

          Zacks Equity Research

          Medical Product Stocks Q4 Earnings Roster: SYK, ISRG, RMD

          by Zacks Equity Research

          Medical is one of the broader sectors among the 16 Zacks sectors that is expected to report earnings growth in the fourth quarter.

            Zacks Equity Research

            The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic

            by Zacks Equity Research

            The Zacks Analyst Blog Highlights: Intuitive Surgical, Stryker and Hologic

              Zacks Equity Research

              Stryker (SYK): Can It Post a Beat this Earnings Season?

              by Zacks Equity Research

              Delving deeper into the fundamentals of Stryker Corporation (SYK), we expect the stock to beat earnings estimates this quarter.

                Zacks Equity Research

                3 Medical Device Stocks Likely to Beat Earnings Estimates

                by Zacks Equity Research

                The likely revocation of the 2.3% medical device excise tax is going to be a big bonus for both the behemoths and small players.

                  Zacks Equity Research

                  Stryker (SYK) to Pay for Rejuvenate and ABG II Modular-Neck

                  by Zacks Equity Research

                  Stryker Corporation (SYK) announced that it has reached an agreement to compensate patients for Rejuvenate and ABG II Modular-Neck surgeries done prior to Dec 19, 2016.

                    Sheraz Mian headshot

                    Top Research Reports for Amazon, Ford & Dow Chemical

                    by Sheraz Mian

                    Today's Research Daily features new research reports on 16 major stocks, including Amazon (AMZN), Dow Chemical (DOW) and Ford (F).

                      Sheraz Mian headshot

                      Fresh Research Reports For Intel (INTC), AT&T (T) & Others

                      by Sheraz Mian

                      Today's must-read reports are for Intel (INTC), Biogen (BIIB) and AT&T (T).

                        David Bartosiak headshot

                        5 Skyrocketing Momentum Stocks

                        by David Bartosiak

                        Five red hot momentum stocks breaking out to new highs

                          Zacks Equity Research

                          MedTech Industry Stock Outlook - Dec. 2015

                          by Zacks Equity Research

                          While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.

                            Zacks Equity Research

                            MedTech Industry Stock Outlook - Dec. 2015

                            by Zacks Equity Research

                            While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.

                              Zacks Equity Research

                              Should You Buy Evolving Trends in Medical Devices?

                              by Zacks Equity Research

                              Given the U.S. government's pushback on tax-dodging, we expected some sloth to creep into the medical device space as far as M&As are concerned. But to our surprise, M&A activity worldwide has remained fairly stable.

                                David Bartosiak headshot

                                Momentum Stock Market Game Plan

                                by David Bartosiak

                                Momentum Stock Strategist David Bartosiak gives Terry Ruffolo the stock market game plan for today

                                  Zacks Equity Research

                                  MedTech Industry Stock Outlook - July/Aug 2015

                                  by Zacks Equity Research

                                  Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.

                                    Zacks Equity Research

                                    MedTech Industry Stock Outlook - July/Aug 2015

                                    by Zacks Equity Research

                                    Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.

                                      David Bartosiak headshot

                                      3 Best Stocks in the Market Today

                                      by David Bartosiak

                                      Stryker and 2 other hard hitting stock buys

                                        Zacks Equity Research

                                        MedTech M&As Continue Regardless of Tax Scenarios

                                        by Zacks Equity Research

                                        MedTech stalwarts are not expected to shy away from hostile acquisition bids this year.